These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3068492)

  • 21. [The isolation of tetanolysin and study of its protective activity].
    Postanogova GV; Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):48-51. PubMed ID: 1867035
    [No Abstract]   [Full Text] [Related]  

  • 22. Tetanus toxin conformation.
    Robinson JP; Holladay LA; Picklesimer JB; Puett D
    Mol Cell Biochem; 1974 Dec; 5(3):147-51. PubMed ID: 4216770
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth of clostridium tetani in vivo.
    Smith JW; MacIver AG
    Prog Drug Res; 1975; 19():384-90. PubMed ID: 769070
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative immunochemical study of the antigenic makeup of native tetanus toxin from sporulating and nonsporulating C1. tetani strains].
    Volgin IuB; Réthy L; Ráskai M
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):47-51. PubMed ID: 821277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Clostridium tetani in human clinical samples using tetX specific primers targeting the neurotoxin.
    Ganesh M; Sheikh NK; Shah P; Mehetre G; Dharne MS; Nagoba BS
    J Infect Public Health; 2016; 9(1):105-9. PubMed ID: 26220795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Production and purification of tetanus toxin].
    Bizzini B; Turpin A; Raynaud M
    Ann Inst Pasteur (Paris); 1969 May; 116(5):686-712. PubMed ID: 5771049
    [No Abstract]   [Full Text] [Related]  

  • 27. Continuous production of highly purified Clostridium tetani toxin.
    Zacharias B
    Prog Immunobiol Stand; 1967; 3():248-51. PubMed ID: 4908598
    [No Abstract]   [Full Text] [Related]  

  • 28. A defined medium for the growth of Clostridium tetani and other anaerobes of clinical interest.
    Watt B; Brown R
    J Med Microbiol; 1975 Feb; 8(1):167-72. PubMed ID: 1092864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of tetanus toxin fragment C.
    Clare J; Sreekrishna K; Romanos M
    Methods Mol Biol; 1998; 103():193-208. PubMed ID: 9680641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Density and distribution of Clostridium tetani in the soil.
    Ebisawa I; Takayanagi M; Kurata M; Kigawa M
    Jpn J Exp Med; 1986 Apr; 56(2):69-74. PubMed ID: 3525907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Attempted modification of VF-medium for the production of Clostridium tetani toxin].
    PETROVIC D; ZUPANSKI M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1952; 4(3-4):170-4. PubMed ID: 12980500
    [No Abstract]   [Full Text] [Related]  

  • 32. Diphtheria toxin: purification and properties.
    Carroll SF; Barbieri JT; Collier RJ
    Methods Enzymol; 1988; 165():68-76. PubMed ID: 3148099
    [No Abstract]   [Full Text] [Related]  

  • 33. EXCESS SUPPLEMENTATION OF CERTAIN AMINO ACIDS TO MEDIUM AND ITS INHIBITORY EFFECT ON TOXIN PRODUCTION BY CLOSTRIDIUM TETANI.
    TSUNASHIMA I; SATO K; SHOJI K; YONEDA M; AMANO T
    Biken J; 1964 Dec; 7():161-3. PubMed ID: 14308866
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzymatic breakdown of tetanus toxin.
    Helting T; Zwister O
    Biochem Biophys Res Commun; 1974 Apr; 57(4):1263-70. PubMed ID: 4208571
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of glutamate on toxin production by Clostridium tetani.
    Mellanby J
    J Gen Microbiol; 1968 Nov; 54(1):77-82. PubMed ID: 4891918
    [No Abstract]   [Full Text] [Related]  

  • 36. Affinity chromatographic purification and characterization of two iodinated tetanus toxin fractions exhibiting different binding properties.
    Lazarovici P; Tayot JL; Yavin E
    Toxicon; 1984; 22(3):401-13. PubMed ID: 6474492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on tetanus toxin and toxoid. 3. Sedimentation of toxin and derivatives obtained by sulphite and aldehyde treatments.
    Dawson DJ; Nichol LW
    Aust J Biol Sci; 1969 Feb; 22(1):247-55. PubMed ID: 4891122
    [No Abstract]   [Full Text] [Related]  

  • 38. Menstrum for culture preservation and medium for seed preparation in a tetanus toxin production process containing no animal or dairy products.
    Fang A; Gerson DF; Demain AL
    Lett Appl Microbiol; 2006 Oct; 43(4):360-3. PubMed ID: 16965364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle extractives in the production of tetanus toxin.
    FISEK NH; MUELLER JH; MILLER PA
    J Bacteriol; 1954 Mar; 67(3):329-34. PubMed ID: 13142999
    [No Abstract]   [Full Text] [Related]  

  • 40. A modified Mueller medium without native protein for tetanus toxin production.
    STONE JL
    Appl Microbiol; 1953 Jul; 1(4):166-8. PubMed ID: 13066025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.